Female Breast Cancer. Stage of Disease at Diagnosis by Year, Delta vs. Non-Delta Regions, 2003-2010
2003^
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 9.8% 15.1%
Localized 45.9% 37.0%
Regional 34.4% 38.4%
Distant 1.6% 1.4%
Unknown 8.2% 8.2%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 23.6% 15.1%
Localized 48.6% 37.7%
Regional 20.7% 35.8%
Distant 5.0% 9.4%
Unknown 2.1% 1.9%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 18.3% 15.3%
Localized 50.6% 41.0%
Regional 24.9% 35.0%
Distant 3.2% 6.5%
Unknown 3.1% 2.3%
2004
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 19.3% 8.2%
Localized 33.3% 31.5%
Regional 36.8% 41.1%
Distant 5.3% 4.1%
Unknown 5.3% 15.1%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 16.4% 15.6%
Localized 45.0% 50.0%
Regional 30.7% 25.0%
Distant 3.6% 3.1%
Unknown 4.3% 6.3%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 15.1% 17.5%
Localized 49.3% 37.0%
Regional 28.5% 35.0%
Distant 3.8% 7.2%
Unknown 3.2% 3.3%
2005
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 20.7% 3.9%
Localized 43.1% 39.0%
Regional 31.0% 27.3%
Distant 3.4% 10.4%
Unknown 1.7% 19.5%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 22.0% 14.5%
Localized 41.7% 24.2%
Regional 32.1% 43.5%
Distant 3.6% 9.7%
Unknown 0.6% 8.1%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 14.9% 15.9%
Localized 49.3% 41.5%
Regional 27.8% 34.1%
Distant 4.9% 5.0%
Unknown 3.1% 3.6%
2006
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 29.9% 12.5%
Localized 37.7% 41.3%
Regional 20.8% 32.5%
Distant 9.1% 8.8%
Unknown 2.6% 5.0%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 15.9% 19.7%
Localized 43.7% 35.5%
Regional 32.5% 30.3%
Distant 3.3% 10.5%
Unknown 4.6% 3.9%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 14.3% 13.5%
Localized 48.6% 39.9%
Regional 29.1% 36.7%
Distant 5.2% 7.6%
Unknown 2.9% 2.3%
2007
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 18.9% 11.9%
Localized 47.2% 33.3%
Regional 17.0% 35.7%
Distant 9.4% 13.1%
Unknown 7.5% 6.0%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 21.0% 21.1%
Localized 40.7% 33.8%
Regional 30.5% 35.2%
Distant 4.2% 4.2%
Unknown 3.6% 5.6%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 17.4% 15.1%
Localized 48.3% 43.5%
Regional 26.1% 29.7%
Distant 5.1% 8.9%
Unknown 3.1% 2.7%
2008
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 12.1% 11.9%
Localized 48.3% 38.6%
Regional 31.0% 35.6%
Distant 3.4% 9.9%
Unknown 5.2% 4.0%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 15.3% 12.9%
Localized 53.0% 29.4%
Regional 27.3% 41.2%
Distant 3.3% 11.8%
Unknown 1.1% 4.7%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 15.0% 14.7%
Localized 52.9% 42.8%
Regional 25.4% 30.8%
Distant 4.0% 8.7%
Unknown 2.7% 3.1%
2009
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 10.8% 16.7%
Localized 56.9% 34.3%
Regional 24.6% 35.3%
Distant 3.1% 6.9%
Unknown 4.6% 6.9%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 23.2% 19.7%
Localized 50.0% 39.5%
Regional 23.2% 31.6%
Distant 3.7% 3.9%
Unknown 0.0% 5.3%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 16.6% 15.1%
Localized 50.5% 43.1%
Regional 26.4% 30.8%
Distant 4.5% 8.1%
Unknown 2.0% 2.9%
2010
Core Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 17.9% 9.5%
Localized 48.2% 47.6%
Regional 23.2% 31.4%
Distant 7.1% 5.7%
Unknown 3.6% 5.7%
Buffer Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 19.5% 16.5%
Localized 49.1% 31.8%
Regional 20.1% 36.5%
Distant 4.4% 14.1%
Unknown 6.9% 1.2%
Non-Delta Region
Stage at
Diagnosis
White Females Black Females
In Situ 17.3% 20.1%
Localized 52.4% 38.4%
Regional 24.5% 33.9%
Distant 4.8% 5.9%
Unknown 1.0% 1.7%
^Use caution when comparing 2003 data to later years.  The staging system changed between 2003 and 2004.
These data were collected by the Mississippi Cancer Registry which participates in the
National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC).
These data were generated and posted on 04/30/2013.